Thomas Helleday Foundation

This early-stage study tests a new drug called Karonudib in 9 adults with blood cancers like leukemia who have run out of standard treatments. The main goal is to check if the drug is safe and tolerable, and to find the right dose for future studies. Researchers will also look fo…